We identified XIST, KCNH7, SYT1 and DIAPH3 as potential factors associated with the proliferation of malignant cells in GBM.<h4>Conclusions</h4>These biomarkers and cell clusters we discovered may serve as targets for treatment. This evidence concerns the gene KCNH7 and glioblastoma.